Director Declaration

31 October 2016

BTG plc - Directorship Notification under Listing Rule 9.6.14

BTG plc announces that it received notification on Friday, 28 October 2016, from Giles Kerr, a non-executive director, that he has been appointed as an independent non-executive Director of Adaptimmune Therapeutics plc with effect from 1 November 2016.

There are no other matters to disclose in accordance with paragraph 9.6.14R of the Listing Rules.

Contacts:

Andy Burrows, Vice President, Corporate and Investor Relations

+44 (0)20 7575 1741

Stuart Hunt, Investor Relations Manager

+44 (0)20 7575 1582